Designing & Developing Next-Generation Antibody-Drug Conjugates

Time: 1:50 pm
day: Track A - Day 2 PM


  • Design and developability assessment is key to select the appropriate combination of antibody, linker and payload for a successful ADC
  • Involvement of a multidisciplinary team of experts in integrated multiple work streams reduces the overall timeline from bench to bedside